BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Swedish Orphan Biovitrum 

SE-112

  76  Stockholm  Sweden
Phone: 46-8-697-20-00 Fax: n/a


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Sobi Publishes Its Report For The First Quarter 2015 5/6/2015 9:17:24 AM
Sobi Release: Early Treatment And A Longer Life - New Orfadin Formats Meet New Patient Needs 5/4/2015 11:30:16 AM
Pfizer (PFE) Confirmed to be Mystery Bidder of $4.3 Billion Sobi 4/30/2015 3:35:43 PM
Invitation - Presentation Of Sobi's First Quarter 2015 4/30/2015 8:56:02 AM
Sobi's Board Of Directors Postpones Annual General Meeting Of Shareholders 4/29/2015 8:31:39 AM
Sobi Release: Statement Regarding Recent Speculation 4/27/2015 9:25:00 AM
Sobi Waves For Sale Sign at Big Pharmas Like Pfizer (PFE), Biogen (BIIB) 4/27/2015 6:42:01 AM
Swedish Orphan Biovitrum (publ) : Sobi Publishes Annual Report 2014 4/15/2015 11:00:55 AM
Notice Of Annual General Meeting In Swedish Orphan Biovitrum (Publ) 3/30/2015 8:56:28 AM
Biogen Idec (BIIB) And Swedish Orphan Biovitrum Announce Positive Top-Line Efficacy And Safety Results From Phase 3 ALPROLIX Pediatric Study 2/27/2015 10:28:34 AM
123456789